Literature DB >> 26924569

Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.

Shigeki Sekine1,2, Satoshi Yamashita3, Taro Tanabe1, Taiki Hashimoto1, Hiroshi Yoshida1, Hirokazu Taniguchi1, Motohiro Kojima4, Kazuya Shinmura5, Yutaka Saito6, Nobuyoshi Hiraoka1,2, Toshikazu Ushijima3, Atsushi Ochiai1,4.   

Abstract

The molecular mechanisms underlying the serrated pathway of colorectal tumourigenesis, particularly those related to traditional serrated adenomas (TSAs), are still poorly understood. In this study, we analysed genetic alterations in 188 colorectal polyps, including hyperplastic polyps, sessile serrated adenomas/polyps (SSA/Ps), TSAs, tubular adenomas, and tubulovillous adenomas by using targeted next-generation sequencing and reverse transcription-PCR. Our analyses showed that most TSAs (71%) contained genetic alterations in WNT pathway components. In particular, PTPRK-RSPO3 fusions (31%) and RNF43 mutations (24%) were frequently and almost exclusively observed in TSAs. Consistent with the WNT pathway activation, immunohistochemical analysis showed diffuse and focal nuclear accumulation of β-catenin in 53% and 30% of TSAs, respectively. APC mutations were observed in tubular and tubulovillous adenomas and in a subset of TSAs. BRAF mutations were exclusively and frequently encountered in serrated lesions. KRAS mutations were observed in all types of polyps, but were most commonly encountered in tubulovillous adenomas and TSAs. This study has demonstrated that TSAs frequently harbour genetic alterations that lead to WNT pathway activation, in addition to BRAF and KRAS mutations. In particular, PTPRK-RSPO3 fusions and RNF43 mutations were found to be characteristic genetic features of TSAs.
Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  R-spondin; RNF43; WNT; large intestine; traditional serrated adenoma

Mesh:

Substances:

Year:  2016        PMID: 26924569     DOI: 10.1002/path.4709

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  The role of APC in WNT pathway activation in serrated neoplasia.

Authors:  Jennifer Borowsky; Troy Dumenil; Mark Bettington; Sally-Ann Pearson; Catherine Bond; Lochlan Fennell; Cheng Liu; Diane McKeone; Christophe Rosty; Ian Brown; Neal Walker; Barbara Leggett; Vicki Whitehall
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

3.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.

Authors:  Shan Li; Marla Lavrijsen; Aron Bakker; Marcin Magierowski; Katarzyna Magierowska; Pengyu Liu; Wenhui Wang; Maikel P Peppelenbosch; Ron Smits
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

4.  Identification of a novel PRR15L-RSPO2 fusion transcript in a sigmoid colon cancer derived from superficially serrated adenoma.

Authors:  Yasuhiko Mizuguchi; Taku Sakamoto; Taiki Hashimoto; Shunsuke Tsukamoto; Satoru Iwasa; Yutaka Saito; Shigeki Sekine
Journal:  Virchows Arch       Date:  2019-06-17       Impact factor: 4.064

5.  Clinicopathological and molecular correlations in traditional serrated adenoma.

Authors:  Shigeki Sekine; Satoshi Yamashita; Masayoshi Yamada; Taiki Hashimoto; Reiko Ogawa; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Toshikazu Ushijima; Yutaka Saito
Journal:  J Gastroenterol       Date:  2020-02-12       Impact factor: 7.527

6.  Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis.

Authors:  Shigeki Sekine; Taisuke Mori; Reiko Ogawa; Masahiro Tanaka; Hiroshi Yoshida; Hirokazu Taniguchi; Takeshi Nakajima; Kokichi Sugano; Teruhiko Yoshida; Mamoru Kato; Eisaku Furukawa; Atsushi Ochiai; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 7.  WNT as a Driver and Dependency in Cancer.

Authors:  Marie J Parsons; Tuomas Tammela; Lukas E Dow
Journal:  Cancer Discov       Date:  2021-09-13       Impact factor: 39.397

8.  Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.

Authors:  Hironori Aoki; Eiichiro Yamamoto; Hiro-O Yamano; Tamotsu Sugai; Tomoaki Kimura; Yoshihito Tanaka; Hiro-O Matsushita; Kenjiro Yoshikawa; Ryo Takagi; Eiji Harada; Michiko Nakaoka; Yuko Yoshida; Taku Harada; Gota Sudo; Makoto Eizuka; Akira Yorozu; Hiroshi Kitajima; Takeshi Niinuma; Masahiro Kai; Masanori Nojima; Hiromu Suzuki; Hiroshi Nakase
Journal:  Dig Dis Sci       Date:  2018-03-15       Impact factor: 3.199

Review 9.  Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact.

Authors:  Chiara Alquati; Anna Prossomariti; Giulia Piazzi; Francesco Buttitta; Franco Bazzoli; Luigi Laghi; Luigi Ricciardiello
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

Review 10.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.